GLP-1 drugs prescribed for purposes other than weight loss (e.g., type 2 diabetes) remain covered under regular Part D with standard cost-sharing rules
Recent research has begun to explore the use of GLP-1 receptor agonists in treating various mental health conditions, including addiction and binge eating disorder
Independent Lab Verification Testing is conducted by Freedom Diagnostics in the USA
While lifestyle changes and conventional treatments may ease symptoms of neuropathy, supplements, such as glutamine, B vitamins, and alpha-lipoic acid, may also help
That increase in growth hormone is what drives the metabolic and body composition changes the peptide is known for
Research shows that, when taken at bedtime, it may help sleep quality without unwanted daytime drowsiness